Figure 3.
(a) Tumor response in HER2+ patients receiving NACT with or without trastuzumab. (b) Evaluation of tumor response in different tumor subtypes.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.